Advanced Search

 

Study ID Status Title Patient Level Data
200622 Recruiting Study 200622: A randomized, double-blind, placebo-controlled study to investigate the efficacy and safety of mepolizumab in the treatment of adolescent and adult subjects with severe hypereosinophilic syndrome
200623 Completed An open label, two-part, Phase I/randomized Phase II study in subjects with relapsed/refractory multiple myeloma to determine a dose of afuresertib for administration in combination with carfilzomib (Part 1) and to investigate the safety, pharmacokinetics, and clinical activity of the combination of afuresertib with carfilzomib compared with carfilzomib alone (Part 2)
200630 Recruiting A Randomised, Double Blind (Sponsor Unblinded), Placebo-Controlled, Single Ascending Dose Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of a IV Dose of GSK2831781 in Healthy Subjects and Patients with Plaque Psoriasis
200632 Completed PGX6847: Exploratory PGx investigation of dabrafenib efficacy in melanoma monotherapy studies BRF113710, BRF113929, and BRF113683
200633 Completed PGX6848: Exploratory PGx investigation of trametinib efficacy in a melanoma monotherapy study MEK114267
200638 Completed Contac Bien Z Adverse Effect Survey
200641 Not yet recruiting PH+oeBE-Patterns of care in HER2+ metastatic Breast cancer in Europe: A representative, retrospective study in France
200697 Completed A Single-Dose, Open-Label, Randomized, Parallel-Group Study to Demonstrate the Bioequivalence of Lamotrigine Dispersible/Chewable Tablet (100mg) and Lamotrigine Compressed Tablet (100mg) in Healthy Chinese Male Subjects Study Listed on ClinicalStudyDataRequest.com
200699 Completed 200699: A Clinical Study to Evaluate Four Doses of Umeclidinium Bromide in Combination with Fluticasone Furoate in COPD Subjects with an Asthmatic Component
200707 Completed Monitoring biomarkers linked to immunosuppression during VEG113046 to predict clinical response to pazopanib and to demonstrate immunostimulatory properties of this molecule
200713 Not yet recruiting Characteristics of out-patients with epilepsy and patterns of antiepileptic drug utilisation in neurology department at tertiary hospitals: A Cross-Sectional Study in China
200719 Terminated Randomized, Double-blind, Multicenter, Phase III Study Comparing the Efficacy and Safety of Retosiban Versus Placebo for Women in Spontaneous Preterm Labor
200721 Active, not recruiting Randomized, Double-blind, Multicenter, Phase III Study Comparing the Efficacy and Safety of Retosiban Versus Atosiban Therapy for Women in Spontaneous Preterm Labor
200722 Recruiting Follow-Up Study to Assess Long-Term Safety and Outcomes in Infants and Children Born to Mothers Participating in Retosiban Treatment Studies
200725 Not yet recruiting TENOZET® Drug Use Investigation
200726 Active, Not Recruiting TENOZET® Special Drug Use Investigation
200773 Completed Pazopanib Sarcoma Named Patient Programme Chart Review
200775 Completed Dabrafenib Melanoma Named Patient Programme Chart Review
200776 Completed Valproate dose reduction and its clinical evaluation by introducing lamotrigine in Japanese women with epilepsy – single arm, multicenter, and open-label study –
200784 Completed A Phase 1, Randomized, Double-Blind (sponsor open), Placebo-Controlled, Single Dose Escalation Trial to Evaluate the Safety, Tolerability Pharmacokinetics and Pharmacodynamics of GSK3050002 (anti-CCL20 monoclonal antibody) in Healthy Male Volunteers
200791 Completed Clinical Pharmacology Reporting and Analysis Plan for a Combined Analyses to Evaluate the Effect of Ofatumumab on Cardiac Repolarization (QTc Duration)
200793 Completed TOCTINO® for severe chronic hand eczema – post observation of successful treated patients in TOCCATA
200794 Completed A Pilot Study to Measure Force Recovery and Protein Synthetic Rates After Unilateral Eccentric Exercise in Healthy Males Volunteers Unaccustomed to Eccentric Exercise
200799 Completed Study to compare immunogenicity of GSK Biologicals' 10Pn-PD-DiT 4-dose presentation to the licensed Synflorix™ (10Pn-PD-DiT) vaccine when co-administered with DTPw-combination vaccine in healthy infants
200806 Completed Immunogenicity and safety study of GSK Biologicals’ quadrivalent influenza vaccine (GSK2282512A) in children 6 to 35 months of age Study Listed on ClinicalStudyDataRequest.com

 

 

For more information on this register please email GSKClinicalSupportHD@gsk.com

GSK-sponsored clinical studies are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.
GSK-sponsored clinical trials are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.

ClinicalTrial.gov is a database that provides summary protocol information for ongoing clinical trials.

IFPMA.org is a search portal provided by the International Federation of Pharamceutical Manufacturers & Associations (IFPMA).

This portal provides a single entry point to search for industry sponsored clinical trials which are on existing registers and databases.

EU Clinical Trials Register is a database of all clinical trials commencing in the European Community from 1 May 2004 onwards. It has been established in accordance with Directive 2001/20/EC.